Press releases

Scholar Rock Reports First Quarter 2020 Financial Results and Highlights Business Progress

Read This Press Release

Scholar Rock Announces Initiation of Patient Dosing in Phase 1 Proof-of-Concept Immuno-Oncology Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy

Read This Press Release

Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Antibodies that Modulate TGFβ Activation

Read This Press Release

Scholar Rock Announces Publication in Science Translational Medicine of Preclinical Data Detailing a Potent and Selective Inhibitor of TGFβ1 Overcoming Primary Resistance to Checkpoint Inhibition

Read This Press Release

Scholar Rock Presents Data for SRK-015 at the Muscular Dystrophy Association Clinical and Scientific Conference

Read This Press Release

Scholar Rock Reports Full Year 2019 Financial Results and Highlights Business Progress

Read This Press Release

Scholar Rock to Present at the Cowen 40th Annual Healthcare Conference

Read This Press Release

Scholar Rock Presents Data for SRK-015 at the SMA Europe 2nd International Scientific Congress

Read This Press Release